A New Treatment Strategy that Reduces Growth/Differentiation Factor-15 in Type-2 Diabetes Mellitus: Major Autohemotherapy: A Pilot Study

Growth/differentiation factor-15 (GDF-15) is a diagnostic and prognostic marker associated with inflammation, renal damage, and cardiovascular risk in type-2 diabetes mellitus. Researchers have proposed treatment targets that reduce GDF-15 levels. Our aim in this study is to investigate the effect o...

Full description

Saved in:
Bibliographic Details
Published inAlternative therapies in health and medicine Vol. 29; no. 7; pp. 30 - 33
Main Authors Yucel, Hasan E, Ilanbey, Bilal
Format Journal Article
LanguageEnglish
Published United States InnoVision Health Media, Inc 01.10.2023
Subjects
Online AccessGet full text

Cover

Loading…